Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 21:29 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,286 | $1.90 Strike: $1.90 | $6,243.40 |
DisclosureSEC source: 0002006956-26-000004 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,607 Underlying: Common Stock · 3,286 shares Expires 2036-09-30 Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:32 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,286 | $1.90 Strike: $1.90 | $6,243.40 |
DisclosureSEC source: 0001950394-26-000004 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,607 Underlying: Common Stock · 3,286 shares Expires 2036-09-30 Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:35 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,286 | $1.90 Strike: $1.90 | $6,243.40 |
DisclosureSEC source: 0002060369-26-000004 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,656 Underlying: Common Stock · 3,286 shares Expires 2036-09-30 Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:38 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,286 | $1.90 Strike: $1.90 | $6,243.40 |
DisclosureSEC source: 0002055040-26-000004 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,656 Underlying: Common Stock · 3,286 shares Expires 2036-09-30 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 16:27 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,854 | $2.19 Strike: $2.19 | $6,250.26 |
DisclosureSEC source: 0002055040-26-000003 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,367 Underlying: Common Stock · 2,854 shares Expires 2036-06-30 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 16:20 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,854 | $2.19 Strike: $2.19 | $6,250.26 |
DisclosureSEC source: 0002006956-26-000003 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,318 Underlying: Common Stock · 2,854 shares Expires 2036-06-30 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 16:29 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,854 | $2.19 Strike: $2.19 | $6,250.26 |
DisclosureSEC source: 0002060369-26-000003 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,367 Underlying: Common Stock · 2,854 shares Expires 2036-06-30 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 16:24 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,854 | $2.19 Strike: $2.19 | $6,250.26 |
DisclosureSEC source: 0001950394-26-000003 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,318 Underlying: Common Stock · 2,854 shares Expires 2036-06-30 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:18 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,205 | $1.95 Strike: $1.95 | $6,249.75 |
DisclosureSEC source: 0002055040-26-000002 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 3,205 shares Expires 2036-03-31 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:03 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,205 | $1.95 Strike: $1.95 | $6,249.75 |
DisclosureSEC source: 0002006956-26-000002 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,464 Underlying: Common Stock · 3,205 shares Expires 2036-03-31 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:21 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,205 | $1.95 Strike: $1.95 | $6,249.75 |
DisclosureSEC source: 0002060369-26-000002 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 3,205 shares Expires 2036-03-31 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:08 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,205 | $1.95 Strike: $1.95 | $6,249.75 |
DisclosureSEC source: 0001950394-26-000002 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,464 Underlying: Common Stock · 3,205 shares Expires 2036-03-31 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 19:17 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,306 | $2.71 Strike: $2.71 | $6,249.26 |
DisclosureSEC source: 0002055040-26-000001 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308 Underlying: Common Stock · 2,306 shares Expires 2035-12-31 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 19:10 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,306 | $2.71 Strike: $2.71 | $6,249.26 |
DisclosureSEC source: 0002006956-26-000001 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 Underlying: Common Stock · 2,306 shares Expires 2035-12-31 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 19:20 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,306 | $2.71 Strike: $2.71 | $6,249.26 |
DisclosureSEC source: 0002060369-26-000001 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308 Underlying: Common Stock · 2,306 shares Expires 2035-12-31 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 19:13 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 2,306 | $2.71 Strike: $2.71 | $6,249.26 |
DisclosureSEC source: 0001950394-26-000001 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 Underlying: Common Stock · 2,306 shares Expires 2035-12-31 Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:20 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,559 | $4.01 Strike: $4.01 | $6,251.59 |
DisclosureSEC source: 0002055040-25-000002 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 1,559 shares Expires 2035-09-30 Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:12 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,559 | $4.01 Strike: $4.01 | $6,251.59 |
DisclosureSEC source: 0002006956-25-000002 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,953 Underlying: Common Stock · 1,559 shares Expires 2035-09-30 Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:23 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,559 | $4.01 Strike: $4.01 | $6,251.59 |
DisclosureSEC source: 0002060369-25-000002 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 1,559 shares Expires 2035-09-30 Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:17 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,559 | $4.01 Strike: $4.01 | $6,251.59 |
DisclosureSEC source: 0001950394-25-000002 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,953 Underlying: Common Stock · 1,559 shares Expires 2035-09-30 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:07 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,736 | $3.60 Strike: $3.60 | $6,249.60 |
DisclosureSEC source: 0001486189-25-000021 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443 Underlying: Common Stock · 1,736 shares Expires 2035-06-30 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:02 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,736 | $3.60 Strike: $3.60 | $6,249.60 |
DisclosureSEC source: 0001486189-25-000019 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,394 Underlying: Common Stock · 1,736 shares Expires 2035-06-30 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:09 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,736 | $3.60 Strike: $3.60 | $6,249.60 |
DisclosureSEC source: 0001486189-25-000022 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443 Underlying: Common Stock · 1,736 shares Expires 2035-06-30 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:05 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,736 | $3.60 Strike: $3.60 | $6,249.60 |
DisclosureSEC source: 0001486189-25-000020 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,394 Underlying: Common Stock · 1,736 shares Expires 2035-06-30 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:17 UTC |
Betts Wendy JDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,939 | $0.33 Strike: $0.33 | $6,249.87 |
DisclosureSEC source: 0001486189-25-000008 · primary_doc.xml · derivative · entry 1 Betts Wendy J · CIK 0002055040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,211 Underlying: Common Stock · 18,939 shares Expires 2035-03-31 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 16:54 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,939 | $0.33 Strike: $0.33 | $6,249.87 |
DisclosureSEC source: 0001486189-25-000007 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,744 Underlying: Common Stock · 18,939 shares Expires 2035-03-31 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:19 UTC |
Fung Peter KDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,939 | $0.33 Strike: $0.33 | $6,249.87 |
DisclosureSEC source: 0001486189-25-000009 · primary_doc.xml · derivative · entry 1 Fung Peter K · CIK 0002060369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,211 Underlying: Common Stock · 18,939 shares Expires 2035-03-31 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 16:40 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,939 | $0.33 Strike: $0.33 | $6,249.87 |
DisclosureSEC source: 0001486189-25-000006 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,744 Underlying: Common Stock · 18,939 shares Expires 2035-03-31 Read SEC document |
| December 31, 2024 Filed Jan 15, 2025 22:04 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 4,544 | $0.92 Strike: $0.92 | $4,180.48 |
DisclosureSEC source: 0001486189-25-000003 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,805 Underlying: Common Stock · 4,544 shares Expires 2034-12-31 Read SEC document |
| December 31, 2024 Filed Jan 15, 2025 21:59 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 4,544 | $0.92 Strike: $0.92 | $4,180.48 |
DisclosureSEC source: 0001486189-25-000002 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,805 Underlying: Common Stock · 4,544 shares Expires 2034-12-31 Read SEC document |
| September 30, 2024 Filed Oct 10, 2024 20:43 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,686 | $0.22 Strike: $0.22 | $4,110.92 |
DisclosureSEC source: 0001486189-24-000051 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,261 Underlying: Common Stock · 18,686 shares Expires 2034-09-30 Read SEC document |
| September 30, 2024 Filed Oct 10, 2024 20:52 UTC |
Levy OdedDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,686 | $0.22 Strike: $0.22 | $4,110.92 |
DisclosureSEC source: 0001486189-24-000054 · primary_doc.xml · derivative · entry 1 Levy Oded · CIK 0001950696 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,261 Underlying: Common Stock · 18,686 shares Expires 2034-09-30 Read SEC document |
| September 30, 2024 Filed Oct 10, 2024 20:50 UTC |
Lau Stanley K.Director
|
GrantStock Options (Right to Buy) · Derivative | 18,686 | $0.22 Strike: $0.22 | $4,110.92 |
DisclosureSEC source: 0001486189-24-000053 · primary_doc.xml · derivative · entry 1 Lau Stanley K. · CIK 0001950824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,261 Underlying: Common Stock · 18,686 shares Expires 2034-09-30 Read SEC document |
| September 30, 2024 Filed Oct 10, 2024 20:47 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 18,686 | $0.22 Strike: $0.22 | $4,110.92 |
DisclosureSEC source: 0001486189-24-000052 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,261 Underlying: Common Stock · 18,686 shares Expires 2034-09-30 Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 15:08 UTC |
Dogan MeeshanthiniChief Technology Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000045 · primary_doc.xml · nonDerivative · entry 1 Dogan Meeshanthini · CIK 0001950789 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,310 F1 · shares: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 15:01 UTC |
Dogan MeeshanthiniDirector · Chief Executive Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000044 · primary_doc.xml · nonDerivative · entry 1 Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,683,867 F1 · shares: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F1 · balance_after: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 1,586,464 shares of common stock held individually and 68,965 shares of common stock held jointly with her spouse who is the issuer's Chief Technology Officer. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:22 UTC |
Philibert RobertDirector · Chief Medical Officer
|
PurchaseCommon Stock | 7,460 | $0.28 | $2,124.61 |
DisclosureSEC source: 0001486189-24-000046 · primary_doc.xml · nonDerivative · entry 2 Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (1) Disclosed balance after: 1,683,867 F1 · ownership.direct: Robert Philibert a Director and Chief Medical Officer (CMO) of the registrant, is the direct owner of 75,676 of the securities of the registrant reported herein, owns and controls BD Holding Inc., the direct owner of 1,586,464 of the securities of the registrant reported herein, owns and controls Behavioral Diagnostics LLC, the direct owner of 14,126 of the securities of the registrant reported herein, and his spouse is the direct owner of 7,601of the securities of the registrant reported herein. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:22 UTC |
Philibert RobertDirector · Chief Medical Officer
|
PurchaseCommon Stock | 26,615 | $0.29 | $7,638.51 |
DisclosureSEC source: 0001486189-24-000046 · primary_doc.xml · nonDerivative · entry 1 Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (1) Disclosed balance after: 1,676,407 F1 · ownership.direct: Robert Philibert a Director and Chief Medical Officer (CMO) of the registrant, is the direct owner of 75,676 of the securities of the registrant reported herein, owns and controls BD Holding Inc., the direct owner of 1,586,464 of the securities of the registrant reported herein, owns and controls Behavioral Diagnostics LLC, the direct owner of 14,126 of the securities of the registrant reported herein, and his spouse is the direct owner of 7,601of the securities of the registrant reported herein. Read SEC document |
| September 06, 2024 Filed Sep 23, 2024 20:24 UTC Amendment |
Dogan TimurChief Technology Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000047 · primary_doc.xml · nonDerivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,310 F1 · shares: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. Read SEC document |
| September 06, 2024 Filed Oct 7, 2024 15:29 UTC Amendment |
Dogan MeeshanthiniDirector · Chief Executive Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000048 · primary_doc.xml · nonDerivative · entry 1 Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,655,429 F1 · shares: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F1 · balance_after: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 1,586,464 shares of common stock held individually and 68,965 shares of common stock held jointly with her spouse who is the issuer's Chief Technology Officer. Read SEC document |
| September 06, 2024 Filed Oct 8, 2024 14:42 UTC Amendment |
Dogan MeeshanthiniDirector · Chief Executive Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000049 · primary_doc.xml · nonDerivative · entry 1 Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,655,429 F1 · shares: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F1 · balance_after: The reporting person holds the shares in an account with her spouse, the issuer's Chief Technology Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 1,586,464 shares of common stock held individually and 68,965 shares of common stock held jointly with her spouse, the issuer's Chief Technology Officer. Read SEC document |
| September 06, 2024 Filed Oct 9, 2024 17:18 UTC Amendment |
Dogan TimurChief Technology Officer
|
PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000050 · primary_doc.xml · nonDerivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,310 F1 · shares: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F1 · balance_after: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:38 UTC |
Burton Paul FrederickDirector
|
GrantStock Options (Right to Buy) · Derivative | 7,575 | $0.55 Strike: $0.55 | $4,166.25 |
DisclosureSEC source: 0001486189-24-000037 · primary_doc.xml · derivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,575 Underlying: Common Stock · 7,575 shares Expires 2034-06-30 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:55 UTC |
Levy OdedDirector
|
GrantStock Options (Right to Buy) · Derivative | 7,575 | $0.55 Strike: $0.55 | $4,166.25 |
DisclosureSEC source: 0001486189-24-000040 · primary_doc.xml · derivative · entry 1 Levy Oded · CIK 0001950696 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,575 Underlying: Common Stock · 7,575 shares Expires 2034-06-30 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:51 UTC |
Lau Stanley K.Director
|
GrantStock Options (Right to Buy) · Derivative | 7,575 | $0.55 Strike: $0.55 | $4,166.25 |
DisclosureSEC source: 0001486189-24-000039 · primary_doc.xml · derivative · entry 1 Lau Stanley K. · CIK 0001950824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,575 Underlying: Common Stock · 7,575 shares Expires 2034-06-30 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:48 UTC |
Intrater JamesDirector
|
GrantStock Options (Right to Buy) · Derivative | 7,575 | $0.55 Strike: $0.55 | $4,166.25 |
DisclosureSEC source: 0001486189-24-000038 · primary_doc.xml · derivative · entry 1 Intrater James · CIK 0001950394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,575 Underlying: Common Stock · 7,575 shares Expires 2034-06-30 Read SEC document |
| March 31, 2024 Filed Apr 8, 2024 19:28 UTC |
Burton Paul FrederickDirector
|
Exercise / conversionRestricted Stock Units · Derivative | Not disclosed | $0.00 Strike: $0.00 | $12,500.00 |
DisclosureSEC source: 0001486189-24-000024 · primary_doc.xml · derivative · entry 2 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · Not disclosed shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. F3 · derivative.exercise_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date. F3 · derivative.expiration_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date. F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. Read SEC document |
| March 31, 2024 Filed Apr 8, 2024 19:28 UTC |
Burton Paul FrederickDirector
|
Exercise / conversionCommon Stock | 8,803 | $1.42 | $12,500.26 |
DisclosureSEC source: 0001486189-24-000024 · primary_doc.xml · nonDerivative · entry 1 Burton Paul Frederick · CIK 0002006956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock. Read SEC document |
| March 31, 2024 Filed Apr 8, 2024 19:22 UTC |
Lau Stanley K.Director
|
Exercise / conversionRestricted Stock Units · Derivative | Not disclosed | $0.00 Strike: $0.00 | $12,500.00 |
DisclosureSEC source: 0001486189-24-000023 · primary_doc.xml · derivative · entry 2 Lau Stanley K. · CIK 0001950824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · Not disclosed shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. F3 · derivative.exercise_date: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. F3 · derivative.expiration_date: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. Read SEC document |
| March 31, 2024 Filed Apr 8, 2024 19:22 UTC |
Lau Stanley K.Director
|
Exercise / conversionCommon Stock | 8,803 | $1.42 | $12,500.26 |
DisclosureSEC source: 0001486189-24-000023 · primary_doc.xml · nonDerivative · entry 1 Lau Stanley K. · CIK 0001950824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.